Literature DB >> 31691905

Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?

Nicoletta Ciccarelli1.   

Abstract

AIMS: The prognosis and the clinical manifestations of HIV infection have changed with the introduction of the potent combination antiretroviral therapy (cART); however, up to 50% of patients meet research criteria for "HIV-associated neurocognitive disorders" (HAND) according with current nosology. The majority of patients affected by HAND, especially in cohorts with suppressed plasma viremia, showed an Asymptomatic Neurocognitive Impairment (ANI), without any functional impairment. After more than 10 years from the introduction of the current so-called "Frascati criteria", this mini-review aimed to address the emerging limitations in current diagnosis procedures.
METHODS: We discussed the most relevant literature on HAND prevalence, etiology, and diagnosis.
RESULTS: We addressed three main emerging issues: (1) the unclear clinical relevance of ANI entity; (2) the evidences that Frascati criteria could produce a significant overestimation of HAND; (3) the need to better identify patients with a higher risk to develop HAND requiring routine neuropsychological examinations.
CONCLUSIONS: Frascati criteria should be updated to better respond to the present characteristics of HIV + cohorts and to help clinicians in their cognitive and global management.

Entities:  

Keywords:  HIV; HIV-associated neurocognitive disorders; Nosology; Risk factors

Mesh:

Year:  2019        PMID: 31691905     DOI: 10.1007/s15010-019-01373-8

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.

Authors:  Mattia Trunfio; Davide De Francesco; Daniela Vai; Caterina Medina; Maurizio Milesi; Simone Domini; Chiara Alcantarini; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  AIDS Behav       Date:  2022-01-04

Review 2.  Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis.

Authors:  Tory P Johnson; Avindra Nath
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

3.  Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.

Authors:  Anna Prats; Ignacio Martínez-Zalacaín; Beatriz Mothe; Eugènia Negredo; Núria Pérez-Álvarez; Maite Garolera; Sira Domènech-Puigcerver; Pep Coll; Michael Meulbroek; Anna Chamorro; Carmina R Fumaz; Maria J Ferrer; Bonaventura Clotet; Carles Soriano-Mas; Jose A Muñoz-Moreno
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

Review 4.  Astrocytes, HIV and the Glymphatic System: A Disease of Disrupted Waste Management?

Authors:  Caitlin Tice; Jane McDevitt; Dianne Langford
Journal:  Front Cell Infect Microbiol       Date:  2020-09-29       Impact factor: 5.293

Review 5.  Transcriptomic and Genetic Profiling of HIV-Associated Neurocognitive Disorders.

Authors:  Daniel Ojeda-Juárez; Marcus Kaul
Journal:  Front Mol Biosci       Date:  2021-10-29

6.  The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.

Authors:  Valentina Delle Donne; Nicoletta Ciccarelli; Valentina Massaroni; Alberto Borghetti; Alex Dusina; Damiano Farinacci; Elena Visconti; Enrica Tamburrini; Massimiliano Fabbiani; Simona Di Giambenedetto
Journal:  J Neurovirol       Date:  2020-08-24       Impact factor: 2.643

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.